Table 1.
Summary of the growth abilities of 18 ORF deletion mutants in vitroa
VZV ORF | Growth in cell line: |
HSV-1 homolog | VZV ORF function | |||
---|---|---|---|---|---|---|
MeWob | ARPE-19b | SOCc | SH-SY5Yb | |||
1 | + | + | + | + | None | Transmembrane protein |
2 | + | + | + | + | None | Unknown |
3 | + | + | + | + | UL55 | Unknown |
7 | + | + | − | − | UL51 | Tegument protein with unknown functiond |
8e | + | + | + | + | UL50 | Deoxyuridine triphosphatase |
10 | + | + | − | + | UL48 | Tegument protein; transactivator of immediate-early genes |
11 | + | + | + | + | UL47 | Tegument protein with unknown functiond |
12 | + | + | + | + | UL46 | Tegument protein with unknown functiond |
13 | + | + | + | + | None | Thymidylate synthase |
14 | + | + | − | + | UL44 | Glycoprotein gC |
15 | + | + | + | + | UL43 | Integral membrane proteind |
36 | + | + | + | + | UL23 | Deoxypyrimidine kinase |
47e | + | + | − | + | UL13 | Serine-threonine kinase |
57 | + | + | + | + | None | Tegument protein; role in virion egress |
58 | + | + | + | + | UL3 | Unknown |
59e | + | + | + | + | UL2 | Uracil-DNA glycosylase |
64/69 | + | + | + | + | US10 | Tegument protein with unknown functiond |
65 | + | + | + | + | US9 | Virion protein involved in axonal transportd |
The growth abilities of 18 dispensable deletion mutants in MeWo cells and ARPE-19 cells compared to their growth in SH-SY5Y cells and human fetal skin organ cultures (SOC). “+” denotes normal growth and “−” denotes defective or null phenotypes for the ORF deletion mutants in the respective cell type or in SOC. The ORF7 deletion mutant was the only mutant with a severe growth defect in SH-SY5Y cells.
Results from this study.
Results from previous studies.
Putative function based on homology.
Partial ORF deletion virus study included.